376 results in Exploration of Targeted Anti-tumor Therapy
Most Viewed
  • Latest
  • Most Viewed
  • Most Downloaded
  • Most Cited
Sort by :
Open Access Original Article
Mutational landscape of epidermoid carcinoma of the penis in a Brazilian cohort
Renato Mendes Rossi De Lucca ... Rodolfo Borges dos Reis
Published: June 06, 2025 Explor Target Antitumor Ther. 2025;6:1002323
2740 20 0
Open Access Review
Metal grafted graphene-based nanomaterials towards cancer theranostic efficacy
Prashant H. Gohil, Gopal Avashthi
Published: November 10, 2025 Explor Target Antitumor Ther. 2025;6:1002346
2742 34 0
Open Access Original Article
Chemotherapy related changes in cfDNA levels in squamous non-small cell lung cancer: correlation with symptom scores and radiological responses
Nithiyanandan Ravi ... Navneet Singh
Published: May 28, 2024 Explor Target Antitumor Ther. 2024;5:508–521
2699 21 2
Open Access Mini Review
Unmasking the microbiome: the hidden role of gut bacteria in the pathogenesis of colorectal cancer and its prevention strategies
Tallha W. Khawaja ... Yujiang Fang
Published: November 24, 2025 Explor Target Antitumor Ther. 2025;6:1002351
2647 27 0
Open Access Review
Therapeutic properties of plant-derived prebiotics in melanoma
Emily Kay ... Seema Nair Parvathy
Published: December 19, 2025 Explor Target Antitumor Ther. 2025;6:1002354
2574 25 1
Open Access Perspective
Implications of noncoding RNAs for cancer therapy: Are we aiming at the right targets?
Amil Shah
Published: January 16, 2025 Explor Target Antitumor Ther. 2025;6:1002286
This article belongs to the special issue Advances in Cancer Genomics and Therapeutic Targets
2501 21 1
Open Access Mini Review
The evolving landscape of first-line and subsequent therapies in EGFR-mutated NSCLC: efficacy, resistance, and tolerability
Carminia Maria Della Corte ... Floriana Morgillo
Published: April 27, 2026 Explor Target Antitumor Ther. 2026;7:1002370
2472 50 0
Open Access Original Article
Aflatoxin B1-DNA adducts modify the effects of post-operative adjuvant transarterial chemoembolization improving hepatocellular carcinoma prognosis
Liyan Huang ... Xidai Long
Published: August 31, 2023 Explor Target Antitumor Ther. 2023;4:780–792
2459 25 1
Open Access Original Article
Novel kinase-activating genetic events in non-small cell lung carcinomas
Elena V. Preobrazhenskaya ... Evgeny N. Imyanitov
Published: July 09, 2025 Explor Target Antitumor Ther. 2025;6:1002330
2383 23 1
Open Access Meeting Abstracts
Selected meeting abstracts of 2nd International Conference on Contemporary Oncology
Chouaib Salem
Published: June 28, 2024 Explor Target Antitumor Ther. 2024;5:789–799
2305 28 0
Open Access Systematic Review
Comparison of weekly docetaxel regimens in prostate cancer: a systematic review and frequentist network meta-analysis
Shree Rath ... Amar Lal
Published: February 27, 2026 Explor Target Antitumor Ther. 2026;7:1002360
2126 41 0
Open Access Case Report
Eosinophil cytolysis with or without ETosis in four cases of human gastric cancer: a comparative ultrastructural study
Rosario Caruso ... Luciana Rigoli
Published: April 21, 2025 Explor Target Antitumor Ther. 2025;6:1002309
2120 15 2
Open Access Case Report
Immune checkpoint inhibitor-induced hemophagocytic lymphohistiocytosis in lung cancer: a case series
Abdul Wali Khan ... Dhruv Bansal
Published: November 12, 2025 Explor Target Antitumor Ther. 2025;6:1002347
1961 28 3
Open Access Mini Review
Benign, persistent, and invasive: mechanistic and translational approaches to middle‑ear cholesteatoma
Pinelopi Samara ... Ioannis Athanasopoulos
Published: February 24, 2026 Explor Target Antitumor Ther. 2026;7:1002359
1838 37 0
Open Access Original Article
Differential molecular mechanisms of bortezomib sensitization to rhTRAIL in non-small cell lung cancer cell lines
Paweł Kochany ... Frank A.E. Kruyt
Published: October 28, 2025 Explor Target Antitumor Ther. 2025;6:1002342
1778 25 0
Open Access Review
Triple-negative breast cancer: current understanding and future perspectives
Alhasan Alobaidi, Vikrant Rai
Published: May 14, 2026 Explor Target Antitumor Ther. 2026;7:1002372
1575 27 0